A pilot phase II trial with arogya-wardhani and Punarnavadi-Kwath in viral hepatitis.
D000328:Adult; D003300:Copper / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006525:Hepatitis, Viral, Human / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007194:India; D007501:Iron / Q000627:therapeutic use; D008297:Male; D008628:Mercury / Q000627:therapeutic use; D008670:Metals / Q000627:therapeutic use*; D008875:Middle Aged; D010936:Plant Extracts / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D013455:Sulfur / Q000627:therapeutic use; D000637:Transaminases / Q000378:metabolism
D004338:Drug Combinations; D008670:Metals; D010936:Plant Extracts; D013455:Sulfur; C020973:arogya-wardhani; C021078:Punarnavadi-kwath; D003300:Copper; D007501:Iron; D000637:Transaminases; D008628:Mercury